Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eirini P Papapetrou

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Trends in Immunology|June 14, 2023
Base editors dissect genetic variants in human hematopoietic cells on a large scaleEirini P Papapetrou
Blood|June 9, 2012
FA iPS: correction or reprogramming first?Eirini P Papapetrou
Experimental Hematology|November 28, 2018
Modeling myeloid malignancies with patient-derived iPSCsEirini P Papapetrou
Cell Stem Cell|April 8, 2022
MDS/AML with del5q: An acquired "laminopathy"?Eirini P Papapetrou
Advances in Experimental Medicine and Biology|November 12, 2017
Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next FrontierEirini P Papapetrou
Science (New York, N.Y.)|October 5, 2016
Induced pluripotent stem cells, past and futureEirini P Papapetrou
Cold Spring Harbor Perspectives in Medicine|August 28, 2019
Modeling Leukemia with Human Induced Pluripotent Stem CellsEirini P Papapetrou
Blood|September 4, 2025
Breaking ribosomes to fight leukemiaEirini P Papapetrou
Nature Medicine|December 7, 2016
Patient-derived induced pluripotent stem cells in cancer research and precision oncologyEirini P Papapetrou
Cell Stem Cell|April 4, 2025
The clones have STRACK: Tracing responses to leukemic mutationsEirini P Papapetrou
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Trends in Immunology|June 14, 2023
Base editors dissect genetic variants in human hematopoietic cells on a large scaleEirini P Papapetrou
Blood|June 9, 2012
FA iPS: correction or reprogramming first?Eirini P Papapetrou
Experimental Hematology|November 28, 2018
Modeling myeloid malignancies with patient-derived iPSCsEirini P Papapetrou
Cell Stem Cell|April 8, 2022
MDS/AML with del5q: An acquired "laminopathy"?Eirini P Papapetrou
Advances in Experimental Medicine and Biology|November 12, 2017
Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next FrontierEirini P Papapetrou
Science (New York, N.Y.)|October 5, 2016
Induced pluripotent stem cells, past and futureEirini P Papapetrou
Cold Spring Harbor Perspectives in Medicine|August 28, 2019
Modeling Leukemia with Human Induced Pluripotent Stem CellsEirini P Papapetrou
Blood|September 4, 2025
Breaking ribosomes to fight leukemiaEirini P Papapetrou
Nature Medicine|December 7, 2016
Patient-derived induced pluripotent stem cells in cancer research and precision oncologyEirini P Papapetrou
Cell Stem Cell|April 4, 2025
The clones have STRACK: Tracing responses to leukemic mutationsEirini P Papapetrou
Pageof 9